Literature DB >> 15971502

Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers - results of German National Health Surveys from 1984 to 1999.

Yong Du1, Hans-Ulrich Melchert, Hildtraud Knopf, Marianne Braemer-Hauth, Barbara Gerding, Ellen Pabel.   

Abstract

Previous studies regarding effects of caffeine on lipids focused mainly on coffee consumption, the real association of serum caffeine concentrations with blood lipids is unclear. 814 caffeine-drug users who had taken any caffeine/caffeine-containing pharmaceutical products and 623 nonusers without any drug use in the last seven days before the medical interview were identified from German National Health Surveys from 1984 to 1999. Serum caffeine concentrations were measured by using EIA for caffeine-drug users and nonusers in the same laboratory. Blood lipids were measured routinely for all survey participants. The association of caffeine concentrations with blood lipids was established by means of partial correlation analysis and regression analysis. After controlling for influence factors, caffeine concentrations were closely positively related to triglycerides in caffeine-drug users (male: r = 0.245, p < 0.001; female: r = 0.117, p = 0.018) and related to HDL-C in female nonusers (r = 0.245, p < 0.001). No associations were found between caffeine concentrations and total cholesterol and LDL-C levels in any groups of our study. Acute intake of caffeine might increase triglycerides levels especially in men while chronic intake of caffeine might be weakly but positively associated with HDL-C concentrations in women. The effects of caffeine on the pathogenesis of cardiovascular diseases should be further confirmed through epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971502     DOI: 10.1007/s10654-004-7536-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  35 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee.

Authors:  A Aro; J Teirilä; C G Gref
Journal:  Atherosclerosis       Date:  1990-08       Impact factor: 5.162

3.  Association of coffee and caffeine intake with the risk of Parkinson disease.

Authors:  G W Ross; R D Abbott; H Petrovitch; D M Morens; A Grandinetti; K H Tung; C M Tanner; K H Masaki; P L Blanchette; J D Curb; J S Popper; L R White
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

4.  Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study.

Authors:  A Rosengren; A Dotevall; L Wilhelmsen; D Thelle; S Johansson
Journal:  J Intern Med       Date:  2004-01       Impact factor: 8.989

5.  Relation of caffeine intake to blood lipids in elderly women.

Authors:  C A Carson; J A Cauley; A W Caggiula
Journal:  Am J Epidemiol       Date:  1993-07-15       Impact factor: 4.897

6.  Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial.

Authors:  H R Superko; W Bortz; P T Williams; J J Albers; P D Wood
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

7.  Coffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women.

Authors:  J Tuomilehto; A Tanskanen; P Pietinen; A Aro; J T Salonen; P Happonen; A Nissinen; P Puska
Journal:  J Epidemiol Community Health       Date:  1987-09       Impact factor: 3.710

8.  Coffee consumption and cognitive function among older adults.

Authors:  Marilyn Johnson-Kozlow; Donna Kritz-Silverstein; Elizabeth Barrett-Connor; Deborah Morton
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

9.  The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate.

Authors:  E Bona; U Adén; B B Fredholm; H Hagberg
Journal:  Pediatr Res       Date:  1995-09       Impact factor: 3.756

10.  Coffee consumption and serum cholesterol in the hypertension detection and follow-up program.

Authors:  B R Davis; J D Curb; N O Borhani; R J Prineas; A Molteni
Journal:  Am J Epidemiol       Date:  1988-07       Impact factor: 4.897

View more
  6 in total

1.  Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes.

Authors:  S Bidel; G Hu; Q Qiao; P Jousilahti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-09-21       Impact factor: 10.122

Review 2.  Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.

Authors:  F Panza; V Solfrizzi; M R Barulli; C Bonfiglio; V Guerra; A Osella; D Seripa; C Sabbà; A Pilotto; G Logroscino
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

Review 3.  Randomized clinical trials of weight loss maintenance: a review.

Authors:  Melanie Warziski Turk; Kyeongra Yang; Marilyn Hravnak; Susan M Sereika; Linda J Ewing; Lora E Burke
Journal:  J Cardiovasc Nurs       Date:  2009 Jan-Feb       Impact factor: 2.083

4.  Chronic Intake of Energy Drinks and Their Sugar Free Substitution Similarly Promotes Metabolic Syndrome.

Authors:  Liam T Graneri; John C L Mamo; Zachary D'Alonzo; Virginie Lam; Ryusuke Takechi
Journal:  Nutrients       Date:  2021-04-06       Impact factor: 5.717

5.  Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.

Authors:  Eduardo E Vargas-Pozada; Erika Ramos-Tovar; Juan D Rodriguez-Callejas; Irina Cardoso-Lezama; Silvia Galindo-Gómez; Daniel Talamás-Lara; Verónica Rocío Vásquez-Garzón; Jaime Arellanes-Robledo; Víctor Tsutsumi; Saúl Villa-Treviño; Pablo Muriel
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

6.  Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan.

Authors:  Hidenobu Takami; Mariko Nakamoto; Hirokazu Uemura; Sakurako Katsuura; Miwa Yamaguchi; Mineyoshi Hiyoshi; Fusakazu Sawachika; Tomoya Juta; Kokichi Arisawa
Journal:  J Epidemiol       Date:  2012-10-06       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.